LOXAPINE | LOXAPINE | ATC N05AH01
NERVOUS SYSTEM ANXIOLYTIC DIBENZOXAZEPINE ANTIPSYCHOTIC AGENTS DOPAMINE ANTAGONISTS TREATMENT OF SCHIZOPHRENIA | ORAL INJECTION INHALATION | Cmax 415 NANOMOLAR Tmax 1.88 HOUR VD 509.8 LITER (EQN) Cl 48.4 LITER / HOUR HT 7.3 HOUR | D(2) DOPAMINE RECEPTOR SEROTONIN 5-HT2 RECEPTOR (PMID24937085) | D2-LIKE DOPAMINE RECEPTOR ANTAGONIST CHEMBL2331075 D2-LIKE DOPAMINE RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |